Abstract
The tumor necrosis factor-α death domain pathway contributes to cellular degeneration in a variety of conditions. This study investigates the hypothesis that this death domain pathway is progressively induced in the brain during the progression of Alzheimer's disease (AD). AD cases had increased levels of proapoptotic markers including tumor necrosis factor-α (TNFα), TNF receptor type 1 (TNF-R1), TNF receptor–associated death domain (TRADD), and caspase-3, 2- to 10-fold higher (P < .01) than age-matched controls and 1 to 3 times higher than transitional cases. In striking contrast, potentially neuroprotective TNF receptor type 2 (TNF-R2), and Fas-associated death domain-like interleukin-1β–converting enzyme (FLICE) inhibitor protein (FLIP) were decreased in AD as compared with age-matched control cases (P < .01). Overall, there was an elevation in proapoptotic elements, including a 5-fold increase in TNF-R1 and a 12-fold decrease in FLIP in AD brains. These changes may translate to increased degenerative potential because the downstream effector caspase-3 and product of the TNF pathway was also increased in parallel with enhanced TNF proapoptotic conditions. Our findings suggest that the TNF death receptor pathway and caspases are activated in the early stages of neuronal degeneration in AD.
Similar content being viewed by others
REFERENCES
Khachaturian, Z. S. 1985. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1097–1105.
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., van Belle, G., and Berg, L. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479–486.
Forloni, G., Chiesa, R., Smiroldo, S., Verga, L., Salmona, M., Tagliavini, F., and Angeretti, N. 1993. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25–35. Neuroreport 4:523–526.
Loo, D. T., Copani, A., Pike, C. J., Whittemore, R. E., Walencewicz, A. J., and Cotman, C. W. 1993. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90:7951–7955.
Su, J. H., Anderson, A. J., Cummings, B. J., and Cotman, C. W. 1994. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5:2529–2533.
Marks, N. and Berg, M. J. 1999. Recent advances on neuronal caspases in development and neurodegeneration. Neurochem. Int. 35:195–220.
Cotman C. W., Ivins K., and Anderson A. J. 1999. Apoptosis in Alzheimer's disease. Pages 347–358, in Terry, R., Katzman, R., Bick, K., and Sisodia, S. (eds.), Alzheimer's Disease, 2nd Ed. Lippincott, Williams & Wilkins, New York.
Wang, S., Rosengren, L. E., Franlund, M., Hamberger, A., and Haglid, K. G. 1999. Bcl-2 expression regulates cell sensitivity to S100beta-mediated apoptosis. Brain. Res. Mol. Brain. Res. 70:167–176.
Ivins, K. J., Bui, E. T., and Cotman, C. W. 1998. Beta-amyloid induces local neurite degeneration in cultured hippocampal neurons: Evidence for neuritic apoptosis. Neurobiol. Dis. 5:365–378.
Ivins, K. J., Thornton, P. L., Rohn, T. T., and Cotman, C. W. 1999. Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. Neurobiol. Dis. 6:440–449.
Raoul, C., Henderson, C. E., and Pettmann, B. 1999. Programmed cell death of embryonic motorneurons triggered through the Fas death receptor. J. Cell. Biol. 147:1049–1062.
Ashkenazi, A. and Dixit, V. M. 1999. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11:255–260.
Colussi, P. A. and Kumar, S. 1999. Targeted disruption of caspase genes in mice: What they tell us about the functions of individual caspases in apoptosis. Immunol. Cell Biol. 77:58–63.
Baker, S. J. and Reddy, E. P. 1998. Modulation of life and death by the TNF receptor superfamily. Oncogene. 17:3261–3270.
Magnusson, C. and Vaux, D. L. 1999. Signalling by CD95 and TNF receptors: Not only life and death. Immunol. Cell Biol. 77:41–46.
Scaffidi, C., Schmitz, I., Krammer, P. H., and Peter, M. E. 1999. The role of c-FLIP in modulation of CD95–induced apoptosis. J. Biol. Chem. 274:1541–1548.
Tschopp, J., Irmler, M., and Thome, M. 1998. Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol. 10:552–558.
Thornberry, N. A. and Lazebnik, Y. 1998. Caspases: enemies within. Science 281:1312–1316.
Darmon, A. J., Ley, T. J., Nicholson, D. W., and Bleackley, R. C. 1996. Cleavage of CPP32 by granzyme B represents a critical role for granzyme B in the induction of target cell DNA fragmentation. J. Biol. Chem. 271:21709–21712.
Datta, R., Banach, D., Kojima, H., Talanian, R. V., Alnemri, E. S., Wong, W. W., and Kufe, D. W. 1996. Activation of the cpp32 protease in apoptosis induced by 1–beta-d-arabinofuranosylcytosine and other DNA-damaging agents. Blood 88:1936–1943.
Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallan, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raja, S. M., Smulson, M. E., Yamin, T.-T., Yu, V. L., and Miller, D. K. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis [see comments]. Nature 376:37–43.
Thornberry, N. A. 1998. Caspases: Key mediators of apoptosis. Chem. Biol. 5:R97–R103.
Mehmet, H. 2000. Caspases find a new place to hide. Nature 403:29–30.
Canu, N., Dus, L., Barbato, C., Ciotti, M. T., Brancolini, C., Rinaldi, A. M., Novak, M., Cattaneo, A., Bradbury, A., and Calissano, P. 1998. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 18:7061–7074.
Cohen, G. M. 1997. Caspases: The executioners of apoptosis. Biochem. J. 326:1–16.
Gervais, F. G., Xu, D., Robertson, G. S., Vaillancourt, J. P., Zhu, Y., Huang, J., LeBlanc, A., Smith, D., Rigby, M., Shearman, M. S., Clarke, E. E., Zheng, H., Van Der Ploeg, L. H., Ruffolo, S. C., Thornberry, N. A., Xanthoudakis, S., Zamboni, R. J., Roy, S., and Nicholson, D. W. 1999. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic Abeta peptide formation. Cell 97:395–406.
Lu, D. C., Rabizadeh, S., Chandra, S., Shayya, R. F., Ellerby, L. M., Ye, X., Salvesen, G. S., Koo, E. H., and Bredesen, D. E. 2000. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor [see comments]. Nat. Med. 6:397–404.
LeBlanc, A., Liu, H., Goodyer, C., Bergeron, C., and Hammond, J. 1999. Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J. Biol. Chem. 274:23426–23436.
Su, J. H., Nichol, K. E., Sitch, T., Sheu, P., Chubb, C., Miller, B. L., Tomaselli, K. J., Kim, R. C., and Cotman, C. W. 2000. DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia. Exp. Neurol. 163:9–19.
Braak, H. and Braak, E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropath. 82:239–259.
Srinivasan, A., Roth, K. A., Sayers, R. O., Shindler, K. S., Wong, A. M., Fritez, L. C., and Tomaselli, K. J. 1998. In Situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differentiation 5:1004–1016.
Biernat, J., Mandelkow, E.-M., Schroter, C., Lichtenberg-Kraag, B., Steiner, B., Berling, B., Meyer, H., Merchen, M., Vandermeeren, A., Goedert, M., and Mandelkow, E. 1992. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motif upstream of the microtubule binding region. EMBO J. 11:1593–1597.
Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., and Lee, V. M.-Y. 1993. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089–1099.
Cummings, B. J., Mason, A. J., Kim, R. C., Sheu, P. C., and Anderson, A. J. 2002. Optimization of techniques for the maximal detection and quantification of Alzheimer's-related neuropathology with digital imaging. Neurobiol. Aging 23:161–170.
Botchkina, G. I., Meistrell, M. E., 3rd, Botchkina, I. L., and Tracey, K. J. 1997. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol. Med. 3:765–781.
Hopkins, S. J. and Rothwell, N. J. 1995. Cytokines and the nervous system. I. Expression and recognition [see comments]. Trends Neurosci. 18:83–88.
Bruunsgaard, H., Andersen-Ranberg, K., Jeune, B., Pedersen, A. N., Skinhoj, P., and Pedersen, B. K. 1999. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J. Gerontol. A. Biol. Sci. Med. Sci. 54:M357–M364.
Tarkowski, E., Blennow, K., Wallin, A., and Tarkowski, A. 1999. Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J. Clin. Immunol. 19:223–230.
Maes, M., DeVos, N., Wauters, A., Demedts, P., Maurits, V. W., Neels, H., Bosmans, E., Altamura, C., Lin, A., Song, C., Vandenbroucke, M., and Scharpe, S. 1999. Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease. J. Psychiatr. Res. 33:397–405.
Aggarwal, S., Gollapudi, S., and Gupta, S. 1999. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J. Immunol. 162:2154–2161.
Venters, H. D., Tang, Q., Liu, Q., VanHoy, R. W., Dantzer, R., and Kelley, K. W. 1999. A new mechanism of neurodegenera-tion: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc. Natl. Acad. Sci. USA 96:9879–9884.
Ashkenazi, A. and Dixit, V. M. 1998. Death receptors: signaling and modulation. Science 281:1305–1308.
Baker, S. J. and Reddy, E. P. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1–9.
Chao, C. C. and Hu, S. 1994. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev. Neurosci. 16:172–179.
Louis, J. C., Magal, E., Takayama, S., and Varon, S. 1993. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259:689–692.
Barger, S. W., Horster, D., Furukawa, K., Goodman, Y., Krieglstein, J., and Mattson, M. P. 1995. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc. Natl. Acad. Sci. USA 92:9328–9332.
Cheng, B., Christakos, S., and Mattson, M. P. 1994. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12:139–153.
Hsu, H., Shu, H. B., Pan, M. G., and Goeddel, D. V. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299–308.
Jiang, Y., Woronicz, J. D., Liu, W., and Goeddel, D. V. 1999. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283:543–546.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhao, M., Cribbs, D.H., Anderson, A.J. et al. The Induction of the TNFα Death Domain Signaling Pathway in Alzheimer's Disease Brain. Neurochem Res 28, 307–318 (2003). https://doi.org/10.1023/A:1022337519035
Issue Date:
DOI: https://doi.org/10.1023/A:1022337519035